Company Filing History:
Years Active: 2025
Title: Matthew Patrick Baumgartner: Innovator in KRas Inhibitors
Introduction
Matthew Patrick Baumgartner is an accomplished inventor based in Aldan, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of KRas inhibitors. His work is vital in advancing treatments for various diseases.
Latest Patents
Matthew holds a patent for KRas inhibitors, which provides compounds of a specific formula aimed at inhibiting the KRas protein. This invention is crucial for developing therapies that target cancer and other related conditions. He has 1 patent to his name.
Career Highlights
Matthew is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions to improve patient outcomes. His expertise in the field has positioned him as a valuable asset to his team.
Collaborations
Matthew has collaborated with notable colleagues, including David Anthony Barda and Jolie Anne Bastian. These partnerships enhance the research efforts at Eli Lilly and Company, fostering an environment of innovation and discovery.
Conclusion
Matthew Patrick Baumgartner exemplifies the spirit of innovation in the pharmaceutical industry. His work on KRas inhibitors showcases his commitment to advancing medical science and improving patient care.